Our sister site, Drug Delivery Business News, reports today that the companies expanded their partnership with plans to make a new health feature available in the Oura Ring app for all U.S. members.
Stelo, Dexcom’s FDA-cleared over-the-counter (OTC) glucose biosensor, now gives users 24/7 glucose insights via the Oura app. Oura’s new in-app metabolic health feature, Glucose, now gives Oura members a deeper understanding of how dietary choices impact health. It provides nutrition and glucose data directly from Stelo in the context of sleep, activity, stress and more.
This latest development builds on a partnership first struck between the companies last fall. The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from the Oura Ring. Combining glucose data with biometrics can deliver a more complete picture of overall health to users. It led to a $200 million fundraising round for Oura, led by Dexcom.
Dexcom says the first-to-market glucose biosensor and smart ring integration can deliver a one-of-a-kind, personalized health experience. It should allow users to better understand links between activity, sleep, stress, nutrition and their glucose.
Get the full story at our sister site, Drug Delivery Business News.
